These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12950336)

  • 21. [Gastrointestinal involvement and the response to dapsone in a case of the urticarial vasculitis syndrome].
    González Quijada S; López Lázaro L; Reinares García L; Borregón Carretero SJ; Sastre Varela J; Estrada Pérez V
    Med Clin (Barc); 1991 Nov; 97(18):706-8. PubMed ID: 1770822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypocomplementemic urticarial vasculitis: report of a pediatric case.
    Cadnapaphornchai MA; Saulsbury FT; Norwood VF
    Pediatr Nephrol; 2000 Apr; 14(4):328-31. PubMed ID: 10775080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dapsone Hypersensitivity Syndrome (DHS): A Detrimental Effect of Dapsone? A Case Report.
    Shukkoor AA; Thangavelu S; George NE; Priya S
    Curr Drug Saf; 2019; 14(1):37-39. PubMed ID: 30062974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dapsone hypersensitivity syndrome with coexisting acute hepatitis E.
    Chogle A; Nagral A; Soni A; Agale S; Jamadar Z
    Indian J Gastroenterol; 2000; 19(2):85-6. PubMed ID: 10812824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The normocomplementemic urticarial vasculitis syndrome--report of a case and response to colchicine.
    Asherson RA; Buchanan N; Kenwright S; Fletcher CM; Hughes GR
    Clin Exp Dermatol; 1991 Nov; 16(6):424-7. PubMed ID: 1806316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria.
    Semira ; Wafai ZA; Zulfkar Q; Sameem F
    Indian J Pharmacol; 2014; 46(4):438-40. PubMed ID: 25097286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dapsone-induced sensory peripheral neuropathy].
    Méry L; Dega H; Prost C; Dubertret L
    Ann Dermatol Venereol; 2003 Apr; 130(4):447-9. PubMed ID: 12843858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dapsone: An Update.
    Karjigi S; Murthy SC; Kallappa H; Kusuma MR; Aruna B; Reddy YN
    Indian J Lepr; 2016 Sep; 87(4):233-239. PubMed ID: 29762952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dapsone hypersensitivity syndrome: a clinico-epidemiological review.
    Agrawal S; Agarwalla A
    J Dermatol; 2005 Nov; 32(11):883-9. PubMed ID: 16361748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dapsone therapy causing sulfone syndrome and lethal hepatic failure in an HIV-infected patient.
    Chalasani P; Baffoe-Bonnie H; Jurado RL
    South Med J; 1994 Nov; 87(11):1145-6. PubMed ID: 7973902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypocomplementemic vasculitis treated with dapsone].
    Hérault M; Mazet J; Beurey P; Cuny JF; Barbaud A; Schmutz JL; Bursztejn AC
    Ann Dermatol Venereol; 2010; 137(8-9):541-5. PubMed ID: 20804899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dapsone syndrome--first Malaysian paediatric case report.
    Zurina Z; Elizawaty O; Thevarajah S; Norlijah O
    Med J Malaysia; 2012 Feb; 67(1):105-7. PubMed ID: 22582558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Urticaria vasculitis and sulfone, a case report].
    Wozel G; Thiele B
    Z Hautkr; 1987 Mar; 62(5):407-9. PubMed ID: 3590913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urticarial vasculitis: response to dapsone and colchicine.
    Muramatsu C; Tanabe E
    J Am Acad Dermatol; 1985 Dec; 13(6):1055. PubMed ID: 4078096
    [No Abstract]   [Full Text] [Related]  

  • 35. Dapsone hypersensitivity syndrome not related to G6PD deficiency.
    Schulkes KJ; Tervaert JW; Rijken F; Haas LE
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26682839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent urticarial eruption in an asthmatic patient.
    Mukkamala R; Baban N; Krishnaswamy G; Smith JK
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):359-64. PubMed ID: 8933773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicities of dapsone in the treatment of cutaneous manifestations of rheumatic diseases.
    Mok CC; Lau CS; Wong RW
    J Rheumatol; 1998 Jun; 25(6):1246-7. PubMed ID: 9632100
    [No Abstract]   [Full Text] [Related]  

  • 38. Sulfone syndrome in a patient receiving steroids for pemphigus.
    Barnard GF; Scharf MJ; Dagher RK
    Am J Gastroenterol; 1994 Nov; 89(11):2057-9. PubMed ID: 7942736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term complete resolution of severe chronic idiopathic urticaria after dapsone treatment.
    Noda S; Asano Y; Sato S
    J Dermatol; 2012 May; 39(5):496-7. PubMed ID: 22126213
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypersensitivity syndrome associated with dapsone/pyrimethamine (Maloprim) antimalaria chemoprophylaxis.
    Thong BY; Leong KP; Chng HH
    Ann Allergy Asthma Immunol; 2002 May; 88(5):527-9. PubMed ID: 12027077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.